The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ibandronate Sodium
Ibandronate Sodium · IBANDRONATE SODIUM 150 mg/1 · Tablet, Film Coated · Oral · Golden State Medical Supply, Inc.
NDC 60429-0643-73 · 3 BLISTER PACK in 1 PACKAGE / 1 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for ibandronate sodium (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Apotex Inc.Canadamanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA078948
- TE code
- AB
- Approval date
- Mar 19, 2012
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ibandronate Sodium (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Golden State Medical Supply, Inc. | IBANDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | IBANDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | IBANDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Apotex Corp | IBANDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
| Apotex Corp. | IBANDRONATE SODIUM 150 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ibandronate Sodium — NDC 60429-0643-73," retrieved September 3, 2026, https://drugdashboards.com/drug/60429064373.
Free to cite with attribution — see how the data is put together.